Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.250
-0.030 (-2.34%)
Apr 29, 2026, 11:58 AM EDT - Market open

Cognition Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-23.49-33.97-25.79-21.4-11.72
Upgrade
Depreciation & Amortization
0.230.270.250.240.09
Upgrade
Other Amortization
----0.38
Upgrade
Loss (Gain) From Sale of Assets
0.04----
Upgrade
Stock-Based Compensation
2.093.754.353.575.18
Upgrade
Other Operating Activities
-0.20.32--0.42
Upgrade
Change in Accounts Receivable
---0.470.12
Upgrade
Change in Accounts Payable
3.511.852.44-0.752.17
Upgrade
Change in Unearned Revenue
-0.7-0.64-1.692.640.5
Upgrade
Change in Other Net Operating Assets
-6.270.074.09-3.30.06
Upgrade
Operating Cash Flow
-24.59-28.47-16.02-18.53-3.63
Upgrade
Capital Expenditures
--0-0.15-0.17-0.03
Upgrade
Sale of Property, Plant & Equipment
0.01----
Upgrade
Investing Cash Flow
0.01-0-0.15-0.17-0.03
Upgrade
Short-Term Debt Repaid
-0.35-0.74-0.81-1.4-0.27
Upgrade
Total Debt Repaid
-0.35-0.74-0.81-1.4-0.27
Upgrade
Net Debt Issued (Repaid)
-0.35-0.74-0.81-1.4-0.27
Upgrade
Issuance of Common Stock
39.3325.765.336.9461.25
Upgrade
Repurchase of Common Stock
-0.16-0.13---
Upgrade
Other Financing Activities
-2.25-1.33---7.78
Upgrade
Financing Cash Flow
36.5723.574.525.5553.2
Upgrade
Foreign Exchange Rate Adjustments
--0-0-0.01
Upgrade
Net Cash Flow
11.99-4.91-11.64-13.1649.53
Upgrade
Free Cash Flow
-24.59-28.48-16.17-18.7-3.66
Upgrade
Free Cash Flow Per Share
-0.34-0.72-0.54-0.79-0.70
Upgrade
Levered Free Cash Flow
-31.39-28.76-23.04-26.27-10.74
Upgrade
Unlevered Free Cash Flow
-31.38-28.75-23.02-26.25-10.56
Upgrade
Change in Working Capital
-3.461.294.85-0.942.84
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.